(Q41156653)

27 September 2017

1 reference

title

A risk-benefit assessment of drugs used in the eradication of Helicobacter pylori infection (English)

1 reference

eradication of infectious diseases

27 September 2017

1 reference

1 reference

A Hackelsberger

1

1 reference

27 September 2017

P Malfertheiner

series ordinal

2

1 reference

27 September 2017

publication date

1 July 1996

1 reference

27 September 2017

1 reference

27 September 2017

volume

15

1 reference

27 September 2017

issue

1

1 reference

27 September 2017

page(s)

30-52

1 reference

https://scigraph.springernature.com/pub.10.2165/00002018-199615010-00003

27 September 2017

exact match

0 references

cites work

Experience with 'triple' anti-Helicobacter pylori eradication therapy: side effects and the importance of testing the pre-treatment bacterial isolate for metronidazole resistance.

1 reference

12 December 2020

Metronidazole resistance in Helicobacter pylori

1 reference

12 December 2020

Fulminant pseudomembranous colitis (PMC) following triple therapy for Helicobacter pylori.

1 reference

12 December 2020

1 reference

12 December 2020

Transmucosal penetration of bismuth particles in the human stomach

1 reference

12 December 2020

Clarithromycin, tetracycline, and bismuth: a new non-metronidazole therapy for Helicobacter pylori infection.

1 reference

12 December 2020

Short report: short-term triple therapy for H. pylori-associated duodenal ulcer disease

1 reference

12 December 2020

Clarithromycin-amoxycillin therapy for Helicobacter pylori infection

1 reference

12 December 2020

Clarithromycin and pseudomembranous enterocolitis

1 reference

12 December 2020

Omeprazole plus amoxicillin: efficacy of various treatment regimens to eradicate Helicobacter pylori

1 reference

12 December 2020

Distinct profiles of gastritis in dyspepsia subgroups. Their different clinical responses to gastritis healing after Helicobacter pylori eradication

1 reference

12 December 2020

Duodenal ulcer healing by eradication of Helicobacter pylori without anti-acid treatment: randomised controlled trial

1 reference

12 December 2020

Helicobacter pylori: controversies and an approach to management

1 reference

12 December 2020

In vitro susceptibility of Helicobacter pylori to the new oral cephalosporins cefpodoxime, ceftibuten and cefixime.

1 reference

12 December 2020

Colloidal bismuth subcitrate and omeprazole inhibit alcohol dehydrogenase mediated acetaldehyde production by Helicobacter pylori

1 reference

12 December 2020

Clarithromycin as monotherapy for eradication of Helicobacter pylori: a randomized, double-blind trial

1 reference

12 December 2020

Penicillin anaphylaxis: a review of sensitization, treatment, and prevention

1 reference

12 December 2020

In vitro susceptibility of Campylobacter pyloridis to cimetidine, sucralfate, bismuth and sixteen antibiotics.

1 reference

12 December 2020

Eradication of Helicobacter pylori reduces the possibility of rebleeding in peptic ulcer disease

1 reference

12 December 2020

Tri-potassium di-citrato bismuthate: a report of its pharmacological properties and therapeutic efficacy in peptic ulcer

1 reference

12 December 2020

Over-the-counter histamine H2-receptor antagonists. How will they affect the treatment of acid-related diseases?

1 reference

12 December 2020

Cost-effectiveness of Helicobacter pylori eradication for the long-term management of duodenal ulcer in Canada

1 reference

12 December 2020

Omeprazole enhances efficacy of triple therapy in eradicating Helicobacter pylori

1 reference

12 December 2020

In vitro selection of resistant Helicobacter pylori

1 reference

12 December 2020

Short report: clarithromycin, an alternative to metronidazole in the triple therapy of Helicobacter pylori infection.

1 reference

12 December 2020

Double-blind trial of omeprazole and amoxicillin to cure Helicobacter pylori infection in patients with duodenal ulcers

1 reference

12 December 2020

Bismuth induced encephalopathy caused by tri potassium dicitrato bismuthate in a patient with chronic renal failure

1 reference

12 December 2020

Effect of ranitidine and amoxicillin plus metronidazole on the eradication of Helicobacter pylori and the recurrence of duodenal ulcer

1 reference

12 December 2020

Cigarette smoking and duodenal ulcer

1 reference

12 December 2020

Effect of acid suppression on efficacy of treatment for Helicobacter pylori infection

1 reference

12 December 2020

Clarithromycin for the eradication of Helicobacter pylori

1 reference

12 December 2020

Intravenous omeprazole/amoxicillin and omeprazole pretreatment in Helicobacter pylori-positive acute peptide ulcer bleeding. A pilot study

1 reference

12 December 2020

Failure of azythromycin to eradicate Campylobacter pylori from the stomach because of acquired resistance during treatment

1 reference

12 December 2020

Potent inhibitory action of the gastric proton pump inhibitor lansoprazole against urease activity of Helicobacter pylori: unique action selective for H. pylori cells

1 reference

12 December 2020

Comparison of tri-potassium di-citrato bismuthate tablets with ranitidine in healing and relapse of duodenal ulcers

1 reference

12 December 2020

Metronidazole susceptibility testing for Helicobacter pylori: comparison of disk, broth, and agar dilution methods and their clinical relevance

1 reference

12 December 2020

The proton pump inhibitor omeprazole inhibits acid survival of Helicobacter pylori by a urease-independent mechanism.

1 reference

12 December 2020

Healing and recurrence of duodenal ulcer after treatment with tripotassium dicitrato bismuthate (TDB) tablets or cimetidine

1 reference

12 December 2020

Campylobacter pyloridis-associated chronic active antral gastritis. A prospective study of its prevalence and the effects of antibacterial and antiulcer treatment

1 reference

12 December 2020

Effect of varying pH on the susceptibility of Campylobacter pylori to antimicrobial agents

1 reference

12 December 2020

Impact of colloidal bismuth subnitrate in the eradication rates of Helicobacter pylori infection-associated duodenal ulcer using a short treatment regimen with omeprazole and clarithromycin: a randomized study

1 reference

12 December 2020

The role of acid inhibition in the treatment of Helicobacter pylori infection

1 reference

12 December 2020

Helicobacter pylori gastritis therapy with omeprazole and clarithromycin increases serum carbamazepine levels

1 reference

12 December 2020

Cytoprotective agents and C. pylori associated acid peptic diseases

1 reference

12 December 2020

[Pseudomembranous colitis caused by antibiotic therapy. Results of a survey of the patient material from the praxis of 900 gastroenterologists]

1 reference

12 December 2020

Effects of verapamil, carbenoxolone and N-acetylcysteine on gastric wall mucus and ulceration in stressed rats

1 reference

12 December 2020

The influence of drug dosage on Helicobacter pylori eradication: a cost-effectiveness analysis.

1 reference

12 December 2020

Risk-benefit assessment of omeprazole in the treatment of gastrointestinal disorders

1 reference

12 December 2020

Low dose, short-term triple therapy for cure of Helicobacter pylori infection and healing of peptic ulcers.

1 reference

12 December 2020

Does omeprazole improve antimicrobial therapy directed towards gastric Campylobacter pylori in patients with antral gastritis? A pilot study.

1 reference

12 December 2020

Rapid eradication of Helicobacter pylori infection.

1 reference

12 December 2020

Randomized study comparing 1 with 2 weeks of quadruple therapy for eradicating Helicobacter pylori.

1 reference

12 December 2020

The who's and when's of therapy for Helicobacter pylori.

1 reference

12 December 2020

Recurrence of duodenal ulcer and Campylobacter pylori infection after eradication

1 reference

12 December 2020

Pseudomembranous colitis following clarithromycin therapy.

1 reference

12 December 2020

Role of Helicobacter pylori eradication in the prevention of peptic ulcer bleeding relapse

1 reference

12 December 2020

The role of antibiotics in Campylobacter pylori associated peptic ulcer disease

1 reference

12 December 2020

Penicillin allergy: a study of incidence as reported by patients

1 reference

12 December 2020

Comparative susceptibilities of Campylobacter pylori to norfloxacin and other agents

1 reference

12 December 2020

An international multi-clinic study comparing the therapeutic efficacy of colloidal bismuth subcitrate coated tablets with chewing tablets in the treatment of duodenal ulceration.

1 reference

12 December 2020

Nucleotide sequence and mutational analysis indicate that two Helicobacter pylori genes encode a P-type ATPase and a cation-binding protein associated with copper transport

1 reference

12 December 2020

Double-blind randomized trial of bismuth subsalicylate and clindamycin for treatment of Helicobacter pylori infection.

1 reference

12 December 2020

Bismuth revisited in Helicobacter pylori gastro-duodenal infection

1 reference

12 December 2020

A randomized study of maintenance therapy with ranitidine to prevent the recurrence of duodenal ulcer

1 reference

12 December 2020

Effect of Helicobacter pylori eradication on peptic ulcer healing

1 reference

12 December 2020

Effect of acid inhibition on Campylobacter pylori.

1 reference

12 December 2020

A comparative safety and efficacy study of clarithromycin and erythromycin stearate in community-acquired pneumonia

1 reference

12 December 2020

Omeprazole therapy for Helicobacter pylori infection.

1 reference

12 December 2020

Long-term prospective study of Helicobacter pylori in nonulcer dyspepsia

1 reference

12 December 2020

Prevention of nitroimidazole resistance in Campylobacter pylori by coadministration of colloidal bismuth subcitrate: clinical and in vitro studies

1 reference

12 December 2020

High prevalence of Helicobacter pylori metronidazole resistance in migrants to east London: relation with previous nitroimidazole exposure and gastroduodenal disease

1 reference

12 December 2020

Omeprazole 40 mg o.m. combined with amoxycillin alone or with amoxycillin and metronidazole in the eradication of Helicobacter pylori

1 reference

12 December 2020

Omeprazole. An update of its pharmacology and therapeutic use in acid-related disorders

1 reference

12 December 2020

De-Nol stimulates gastric and duodenal alkaline secretion through prostaglandin dependent mechanism

1 reference

12 December 2020

Evaluation of Helicobacter pylori sensitivity to amoxycillin and metronidazole in dyspeptic patients.

1 reference

12 December 2020

One week's anti-Helicobacter pylori treatment for duodenal ulcer

1 reference

12 December 2020

Cost-effectiveness of treatment regimens for the eradication of Helicobacter pylori in duodenal ulcer

1 reference

12 December 2020

Duodenal ulcer, Campylobacter pylori, and the "leaking roof" concept

1 reference

12 December 2020

Successful Helicobacter pylori eradication: a systemic effect of antibiotics?

1 reference

12 December 2020

Review article: Helicobacter pylori eradication--understandable caution but no excuse for inertia

1 reference

12 December 2020

Explanations for high rates of eradication with triple therapy using metronidazole in patients harboring metronidazole-resistant Helicobacter pylori strains

1 reference

12 December 2020

Results of a multicentre European survey in 1991 of metronidazole resistance in Helicobacter pylori. European Study Group on Antibiotic Susceptibility of Helicobacter pylori

1 reference

12 December 2020

Metronidazole, omeprazole and clarithromycin: an effective combination therapy for Helicobacter pylori infection

1 reference

12 December 2020

A potential mechanism of action of colloidal bismuth subcitrate: diffusion barrier to hydrochloric acid

1 reference

12 December 2020

Helicobacter pylori eradication reduces the rate of rebleeding in ulcer hemorrhage

1 reference

12 December 2020

A critique of therapeutic trials in Helicobacter pylori-positive functional dyspepsia.

1 reference

12 December 2020

Medical status of patients attending a primary care dental practice in Ireland

1 reference

12 December 2020

High-dose omeprazole plus amoxicillin or clarithromycin cures Helicobacter pylori infection in duodenal ulcer disease

1 reference

12 December 2020

Studies on the mechanism of action of colloidal bismuth subcitrate. I. Interaction with sulfhydryls

1 reference

12 December 2020

Dyspepsia in healthy blood donors

1 reference

12 December 2020

Helicobacter pylori eradication: efficacy and side effect profile of a combination of omeprazole, amoxycillin and metronidazole compared with four alternative regimens.

1 reference

12 December 2020

Lansoprazole, a novel benzimidazole proton pump inhibitor, and its related compounds have selective activity against Helicobacter pylori

1 reference

12 December 2020

Maintenance therapy with colloidal bismuth subcitrate in duodenal ulcer disease

1 reference

12 December 2020

Omeprazole plus amoxicillin for cure of Helicobacter pylori infection. Factors influencing the treatment success

1 reference

12 December 2020

Does a previous course of tripotassium dicitrato bismuthate affect the subsequent chances of successful Helicobacter pylori eradication?

1 reference

12 December 2020

Penicillin anaphylaxis: fatality in elderly patients without a history of penicillin allergy

1 reference

12 December 2020

Omeprazole/amoxicillin: impaired eradication of Helicobacter pylori in smoking but not in premedication with omeprazole

1 reference

12 December 2020

Absorption and elimination of bismuth from oral doses of tripotassium dicitrato bismuthate

1 reference

12 December 2020

Helicobacter pylori eradication in a clinical setting: success rates and the effect on the quality of life in peptic ulcer.

1 reference

12 December 2020

Helicobacter pylori and duodenal ulcer recurrence

1 reference

12 December 2020

The minimum inhibitory and bactericidal concentrations of antibiotics and anti-ulcer agents against Campylobacter pyloridis.

1 reference

12 December 2020

Risk factors for delayed healing of duodenal ulcers treated with famotidine and ranitidine

1 reference

12 December 2020

One week eradication regimen for Helicobacter pylori

1 reference

12 December 2020

Studies on the absorption and excretion of tripotassium dicitrato-bismuthate in man

1 reference

12 December 2020

Bismuth absorption from the colloidal subcitrate

1 reference

12 December 2020

Helicobacter pylori reinfection 4 years post-eradication

1 reference

12 December 2020

Efficacy and side effects of a triple drug regimen for the eradication of Helicobacter pylori.

1 reference

12 December 2020

Effect of administration of ranitidine bismuth citrate with food on the suppression and eradication of Helicobacter pylori in infected volunteers.

1 reference

12 December 2020

Long-term follow-up after eradication of Helicobacter pylori with a combination of omeprazole and amoxycillin

1 reference

12 December 2020

Helicobacter pylori infection in a pediatric population: in vitro susceptibilities to omeprazole and eight antimicrobial agents

1 reference

12 December 2020

Campylobacter pylori: Swedish experiences

1 reference

12 December 2020

Susceptibility of clinical isolates of Campylobacter pyloridis to 11 antimicrobial agents

1 reference

12 December 2020

Secretion of intravenously administered antibiotics in gastric juice: implications for management of Helicobacter pylori

1 reference

12 December 2020

Colloidal bismuth subcitrate. A review of its pharmacodynamic and pharmacokinetic properties, and its therapeutic use in peptic ulcer disease

1 reference

12 December 2020

Treatment failure of ofloxacin in Campylobacter pylori infection

1 reference

12 December 2020

Antibacterial treatment of gastric ulcers associated with Helicobacter pylori

1 reference

12 December 2020

Difference in relapse rates of duodenal ulcer after healing with cimetidine or tripotassium dicitrato bismuthate

1 reference

12 December 2020

Prospective multicentre study of risk factors associated with delayed healing of recurrent duodenal ulcers (RUDER). RUDER Study Group

1 reference

12 December 2020

[Helicobacter pylori resistance against metronidazole in Switzerland: implications for eradication therapy?]

1 reference

12 December 2020

Omeprazole and Helicobacter pylori: temporary suppression rather than true eradication

1 reference

12 December 2020

Medium- or high-dose omeprazole plus amoxicillin eradicates Helicobacter pylori in gastric ulcer disease.

1 reference

12 December 2020

Eradicating Helicobacter pylori and symptoms of non-ulcer dyspepsia

1 reference

12 December 2020

Lack of eradication of Helicobacter pylori after omeprazole

1 reference

12 December 2020

Medium-term results of oral and intravenous omeprazole/amoxicillin Helicobacter pylori eradication therapy

1 reference

12 December 2020

Effect of pH variation on the susceptibility of Helicobacter pylori to three macrolide antimicrobial agents and temafloxacin.

1 reference

12 December 2020

Meta-analysis of the efficacy of antibiotic therapy in eradicating Helicobacter pylori

1 reference

12 December 2020

Influence of cigarette smoking on healing and relapse in duodenal ulcer disease

1 reference

12 December 2020

Antimicrobial agents implicated in Clostridium difficile toxin-associated diarrhea of colitis

1 reference

12 December 2020

Omeprazole/amoxicillin: improved eradication of Helicobacter pylori in smokers because of N-acetylcysteine

1 reference

12 December 2020

Patient factors affecting Helicobacter pylori eradication with triple therapy

1 reference

12 December 2020

Short report: smoking habits and the acquisition of metronidazole resistance in patients with Helicobacter pylori-related gastritis.

1 reference

12 December 2020

Histamine2-receptor antagonists. Standard therapy for acid-peptic diseases. 1.

1 reference

12 December 2020

Impact of metronidazole resistance on the eradication of Helicobacter pylori.

1 reference

12 December 2020

Antibacterial activity of pantoprazole and omeprazole againstHelicobacter pylori

1 reference

12 December 2020

The absorption of bismuth from oral doses of tripotassium dicitrato bismuthate

1 reference

12 December 2020

Unidentified curved bacilli in the stomach of patients with gastritis and peptic ulceration

1 reference

12 December 2020

Lansoprazole. A review of its pharmacodynamic and pharmacokinetic properties and its therapeutic efficacy in acid-related disorders

1 reference

12 December 2020

Treatment of Helicobacter pylori reduces the rate of rebleeding in peptic ulcer disease

1 reference

12 December 2020

Compliance, adverse events and antibiotic resistance in Helicobacter pylori treatment.

1 reference

12 December 2020

Effectiveness of a five times daily triple therapy regimen against Helicobacter pylori

1 reference

12 December 2020

Medium- and high-dose omeprazole plus amoxicillin for eradication of Helicobacter pylori in duodenal ulcer disease

1 reference

12 December 2020

Proposed mechanism for metronidazole resistance in Helicobacter pylori

1 reference

12 December 2020

Effect of omeprazole on duodenal ulcer-associated antral gastritis andHelicobacter pylori

1 reference

12 December 2020

The safety profile of De-Nol

1 reference

12 December 2020

Histamine2-receptor antagonists. Standard therapy for acid-peptic diseases (2)

1 reference

12 December 2020

[Short-term triple therapy with pantoprazole, clarithromycin and metronidazole for the healing of Helicobacter pylori infection]

1 reference

12 December 2020

Quality of life and relapse of duodenal ulcer before and after eradication of Helicobacter pylori.

1 reference

12 December 2020

Changes in the intragastric distribution of Helicobacter pylori during treatment with omeprazole

1 reference

12 December 2020

Modified short-term triple therapy--ranitidine, clarithromycin, and metronidazole--for cure of Helicobacter pylori infection.

1 reference

12 December 2020

[Occurrence of Helicobacter pylori strains resistant to metronidazole]

1 reference

12 December 2020

One-week low-dose triple therapy for the eradication of Helicobacter pylori infection

1 reference

12 December 2020

Eradication of Helicobacter pylori with lansoprazole and clarithromycin

1 reference

12 December 2020

Failure of ciprofloxacin to eradicate Campylobacter pylori from the stomach

1 reference

12 December 2020

Factors influencing the eradication of Helicobacter pylori with triple therapy

1 reference

12 December 2020

Eradication of Helicobacter pylori with clarithromycin and omeprazole

1 reference

12 December 2020

Relapse of duodenal ulcer: does it matter which drug is used in initial treatment?

1 reference

12 December 2020

RUDER--a prospective, two-year, multicenter study of risk factors for duodenal ulcer relapse during maintenance therapy with ranitidine. RUDER Study Group

1 reference

12 December 2020

Patterns of care and expenditures by California Medicaid for peptic ulcer and other acid-related diseases

1 reference

12 December 2020

Review article: treatments that impact favourably upon the eradication of Helicobacter pylori and ulcer recurrence

1 reference

12 December 2020

Use of high efficacy, lower dose triple therapy to reduce side effects of eradicating Helicobacter pylori

1 reference

12 December 2020

Role of metronidazole resistance in therapy of Helicobacter pylori infections

1 reference

12 December 2020

Natural history of Campylobacter pylori in duodenal ulceration treated with an H2-antagonist

1 reference

12 December 2020

Campylobacter pylori and non-ulcer dyspepsia

1 reference

12 December 2020

Only four days of quadruple therapy can effectively cure Helicobacter pylori infection.

1 reference

12 December 2020

Costs of duodenal ulcer therapy with antibiotics.

1 reference

12 December 2020

Amoxicillin plus omeprazole versus triple therapy for eradication of Helicobacter pylori in duodenal ulcer disease: a prospective, randomized, and controlled study

1 reference

12 December 2020

Short report: omeprazole plus antibiotic combinations for the eradication of metronidazole-resistant Helicobacter pylori

1 reference

12 December 2020

Ranitidine. An updated review of its pharmacodynamic and pharmacokinetic properties and therapeutic use in peptic ulcer disease and other allied diseases

1 reference

12 December 2020

Campylobacter pyloridis and associated gastritis: investigator blind, placebo controlled trial of bismuth salicylate and erythromycin ethylsuccinate

1 reference

12 December 2020

Omeprazole-induced increase in the absorption of bismuth from tripotassium dicitrato bismuthate

1 reference

12 December 2020

Lansoprazole. A reappraisal of its pharmacodynamic and pharmacokinetic properties, and its therapeutic efficacy in acid-related disorders

1 reference

12 December 2020

Duodenal ulcer treated with Helicobacter pylori eradication: seven-year follow-up

1 reference

12 December 2020

Phospholipase activity of Helicobacter pylori and its inhibition by bismuth salts. Biochemical and biophysical studies

1 reference

12 December 2020

Pharmacology of bismuth-containing compounds.

1 reference

12 December 2020

Omeprazole therapy modifies the gastric localization of Helicobacter pylori

1 reference

12 December 2020

Peripheral neuropathy induced by metronidazole

1 reference

12 December 2020

No effect of omeprazole-induced hypoacidity on the bioavailability of amoxycillin or bacampicillin

1 reference

12 December 2020

Eradication of Helicobacter pylori in patients with non-ulcer dyspepsia.

1 reference

12 December 2020

NIH Consensus Conference. Helicobacter pylori in peptic ulcer disease. NIH Consensus Development Panel on Helicobacter pylori in Peptic Ulcer Disease

1 reference

12 December 2020

Bismuth accumulates in the body during treatment with tripotassium dicitrato bismuthate

1 reference

12 December 2020

Susceptibility of clinical isolates of Campylobacter pylori to twenty-one antimicrobial agents

1 reference

12 December 2020

Clarithromycin. A review of its antimicrobial activity, pharmacokinetic properties and therapeutic potential

1 reference

12 December 2020

Current status of maintenance therapy in peptic ulcer disease. The ACG Committee on FDA-Related Matters

1 reference

12 December 2020

Hp and pH: implications for the eradication of Helicobacter pylori.

1 reference

12 December 2020

Amoxycillin capsules with omeprazole for the eradication of Helicobacter pylori. Assessment of the importance of antibiotic dose timing in relation to meals

1 reference

12 December 2020

Unidentified curved bacilli on gastric epithelium in active chronic gastritis

1 reference

12 December 2020

Inhibitory antimicrobial concentrations against Campylobacter pylori in gastric mucosa

1 reference

12 December 2020

Hepatitis associated with amoxycillin-clavulanic acid combination report of 15 cases

1 reference

12 December 2020

Effects of omeprazole on neutrophil chemotaxis, super oxide production, degranulation, and translocation of cytochrome b-245

1 reference

12 December 2020

Symptoms, gastritis, and Helicobacter pylori in patients referred for endoscopy

1 reference

12 December 2020

Gastric anti-secretory, mucosal protective, anti-pepsin and anti-Helicobacter properties of ranitidine bismuth citrate

1 reference

12 December 2020

Susceptibility of Campylobacter pylori to macrolides and fluoroquinolones.

1 reference

12 December 2020

10.2165/00002018-199615010-00003

Identifiers

DOI

1 reference

Dimensions Publication ID

27 September 2017

1029204304

0 references

1 reference